Molecular Targeted Therapy of Lung Cancer 1st ed

[amazon template=image&asin=9811020000]

This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also outlines the increasing necessity for new diagnostic technology and strategies for managing different adverse effects and novel methods for evaluating effectiveness and safety.
Edited and authored by opinion leaders, Molecular Targeted Therapy of Lung Cancer provides a comprehensive overview of the disease and its treatments. It is a valuable resource for graduate students, post-doctoral fellows and faculty staff, as well as researchers involved in clinical and translational research on lung cancer, helping promote new ideas for further advances.


Multimodality Treatment of Lung Cancer (Lung Biology in Health and Disease) 1st Edition

[amazon template=image&asin=0824729579]

Edited by the organizer of a pioneering, multidisciplinary clinic for lung cancer patients, now emulated at cancer centers worldwide!
This up-to-date reference presents the treatment and management of lung cancer, as well as accurate evaluation and assessment procedures for small-cell and non-small-cell lung cancers, written by experts in various disciplines of the subject, including biology, chemoprevention, radiographic and surgical staging, and video-assisted thoracoscopic surgery.
Offering a better understanding of the molecular events leading to lung cancer for improved therapeutic strategies, response rates, and cure rates, Multimodality Treatment of Lung Cancer

  • discusses recent advances in the biology of lung cancer such as the role of oncogenes, tumor suppressor genes, and the role of telomerase in carcinogenesis
  • details cellular and biological processes operating in malignant cells
  • compares ongoing international chemoprevention trials in lung, head, and neck cancer
  • contrasts cost advantages and disadvantages of several noninvasive procedures, including chest x-ray, CT, and MRI scans
  • illustrates the newest TNM staging classification system, including mediastinoscopy in assessment of the mediastinum
  • emphasizes technological advances in VATS procedure for evaluating and treating lung cancer with lower morbidity and cost
  • furnishes a thorough review of all active chemotherapeutic agents and modern chemotherapy regimens
  • explores new drugs and drug combinations measured for activity, as well as toxicity in preclinical animal model systems
  • and more!
    Featuring over 1000 references, tables, micrographs, x-rays, and illustrations, Multimodality Treatment of Lung Cancer is an excellent hands-on reference for pulmonologists and pulmonary disease specialists, oncologists, thoracic surgeons, radiologists and radiation therapists, oncoradiologists, pathologists, epidemiologists, physiologists, molecular and cellular biologists, public health professionals, regulatory and public health policy personnel, and graduate and medical students in these disciplines.



Recurrent Respiratory Papillomatosis 1st ed. 2018 Edition

[amazon template=image&asin=331963822X]

This volume provides a comprehensive review of recurrent respiratory papillomatosis and an up-to-date understanding of the etiology, pathophysiology, and management of these rare tumors caused by the human papillomavirus (HPV). The text covers the potential role of vaccines, its significant role in prevention and the controversy surrounding the use of them. Topics such as impact, quality of life, and patient advocacy are also covered and are vital to understanding the disease from the patient perspective.

Recurrent Respiratory Papillomatosis will be an invaluable resource for practicing otolaryngologists, laryngologists, anesthesiologists, infectious disease specialists, and residents participating in the care of patients with this disease.


Lung Cancer and Personalized Medicine: Current Knowledge and Therapies (Advances in Experimental Medicine and Biology) 1st ed

[amazon template=image&asin=3319242210]

From the Back Cover

Pulmonary Vasculature Redox Signaling in Health and Disease (Advances in Experimental Medicine and Biology) 1st ed. 2017 Edition

[amazon template=image&asin=3319632442]

Dr. Yong-Xiao Wang is a Full Professor in the Department of Molecular and Cellular Physiology at Albany Medical College, Albany, New York, USA. He received his M.D. at the Wannan Medical College (China), Ph.D. at the Fourth Military Medical University (China), and postdoctoral training at the Technical University of Munich (Germany) as well as the University of Pennsylvania (USA). Dr. Wang’s primary research interests have focused on basic, translational, and drug discovery research concerning cardiac arrhythmias and hypertrophy, pulmonary hypertension, asthma, and diabetes for over 30 years. In particular, he has had extensive research experience in the studies of the molecular geneses, regulatory mechanisms, network pathways, physiological functions, and the critical roles of calcium, redox, inflammatory, and other signaling in the aforementioned illnesses. Dr. Wang has been the corresponding author, first author, and key contributor in numerous publications in highly peer-reviewed journals including Antioxid Redox Signal, Proc Natl Acad Sci USA, Free Radic Biol Med, Cell Calcium, J Gen Physiol, J Biol Chem, FASEB J, Nature, Circ Res, and more. He has been the editor of several academic books in the field including a recent one entitled “Calcium Signaling in Airway Smooth Muscle Cells” that was published by Springer in 2014. Dr. Wang has been the principal investigator on multiple research grants and awards from the National Institutes of Health, American Heart Association, American Diabetes Association, and other agencies. He has collaborated with numerous well-known scientists, served on various grant review panels, been the Editor-In-Chief and Editorial Board Member for several scientific journals, and trained a number of scholars, some of whom have become well-known independent investigators in the field.


Human Respiratory Viral Infections 1st Edition

[amazon template=image&asin=1466583207]

Using a multidisciplinary approach, Human Respiratory Viral Infections is set at the level between the definitive reference work and an essential clinical manual. Exploring recent advances in human respiratory viral research, the text builds on the basic sciences of epidemiology, virology, molecular biology, and immunology to cover clinical diagnosis, mechanism of pathogenesis, manifestations of disease, impact, treatment, and management strategies.

  • Provides a comprehensive review of all the major human respiratory viral infections
  • Supplies a detailed description of the anatomy of the respiratory system
  • Discusses the salient features of specific viruses
  • Examines the latest diagnostic tools
  • Covers risk factors associated with incidence of respiratory viral infections in children and adults in different occupational and environmental settings

Presenting the latest knowledge in human respiratory viral infections, this text will be immensely valuable for pulmonologists, biomedical scientists, research scholars, virologists, vaccinologists, immunologists, clinicians, pharmacologists, and public health specialists.


Guidelines for Pulmonary Rehabilitation Programs-4th Edition 4th Edition

[amazon template=image&asin=0736096531]

In recent years, the climate surrounding the development and implementation of pulmonary rehabilitation programs has continued to evolve. Legal changes regarding program funding, compensation, and staffing are more dependent on effective certified pulmonary rehabilitation programming. To help those programs develop and succeed, the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) has updated the Guidelines for Pulmonary Rehabilitation Programs to address the credentialing requirements.

This revised fourth edition presents the most current best practices for the application of this complex and evolving clinical intervention. It discusses the individuated and interrelated components of pulmonary rehabilitation, including initial and ongoing assessment, collaborative self-management education, exercise training, psychosocial support, and outcomes measurement. This text also provides a scientific, practical framework to help practitioners do the following:

•Understand the current requirements for accrediting pulmonary-based facilities

•Design, implement, or update accredited pulmonary rehabilitation programs

•Deliver optimal care to people with symptomatic respiratory needs

•Address program issues in exercise, outcomes, and management of pulmonary-based programs

Guidelines for Pulmonary Rehabilitation Programs, Fourth Edition, is based on the most current scientific evidence and includes contributions from expert pulmonary rehabilitation professionals in nursing, medicine, physical therapy, respiratory therapy, and exercise physiology. In the fourth edition, readers will find significant updates and expanded discussion on the topic of psychosocial assessment. The fourth edition also includes a dedicated chapter detailing the AACVPR program certification process. In addition, readers will have access to updated appendixes, including a comprehensive set of forms, guidelines, questionnaires, and assessment tools.

With continued advancements in the science, application, and credentialing of pulmonary rehabilitation programs, the fourth edition of Guidelines for Pulmonary Rehabilitation Programs will assist practitioners in remaining up to date on the best practices in the field. This edition will become a valuable tool in assisting practitioners in understanding the components of pulmonary rehabilitation and applying best practices as well as updating and improving their existing programs to meet AACVPR certification requirements.


Pulmonary Care and Clinical Medicine (Advances in Experimental Medicine and Biology) 1st ed. 2017 Edition

[amazon template=image&asin=3319654683]

This book examines a range of contemporary ideas and arguments concerning the core yet unsettled clinical issues. Important aspects of pulmonary disorders are tackled such as occupational and environmental respiratory health hazards, the role of vitamin D supplementation in airway allergy, or nutritional aspects of care for lung cancer patients. Metabolic disorders affecting the processes of atherogenesis and systemic inflammation also are tackled. Attention is directed to rare but severe pediatric disease entities. Articles give readers practice at analyzing clinical data. The practical insights emphasize the role of science in transforming biomedical knowledge and care. This volume will be essential reading for clinicians, researchers, and other healthcare professionals engaged in effective patient care and therapy.


Handbook of Tuberculosis 1st Edition

[amazon template=iframe image2&asin=3527316833]

About the Author

Diagnosis and Treatment of Pulmonary Hypertension: From Bench to Bedside 1st ed. 2017 Edition

[amazon template=iframe image2&asin=9812878394]

This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH.
This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function.


1 7 8 9 10 11 15